History of NOGG
The National Osteoporosis Guideline Group (NOGG) is a multidisciplinary group that includes patient representation and professionals involved in the care of people with osteoporosis. The NOGG was set up in 2007, to update earlier guidelines developed by the Royal College of Physicians (RCP) for the prevention and treatment of osteoporosis, producing its first guideline in 2008. This has since undergone substantial updates in 2013 and 2017, with minor updates made in 2019. The 2017 NOGG guidance was accredited by NICE in 2017. The new 2021 NOGG guideline was re-accredited by NICE in October 2021.
Structure of NOGG
The NOGG Guideline Writing Group is separated into a Guideline Development Group (GDG) and an Expert Advisory Group (EAG). The GDG is formed by members with no or only minimal potential conflicts of interest. Voting on recommendations is restricted to the GDG and where potential conflicts are declared, the member involved does not take part in the decision about any recommendations that are relevant to the disclosure. The EAG provides input into discussions about guideline revisions but is excluded from voting on the recommendations. No external funding has been received for the development of the NOGG guideline. All members self-fund their (virtual) attendance at regular NOGG meetings.
Guideline Development Group
Prof. Celia L Gregson (Chair)
Professor of Clinical Epidemiology and Honorary Consultant Orthogeriatrician
Musculoskeletal Research Unit, Bristol Medical School, University of Bristol, Bristol, UK and Royal United Hospital NHS Foundation Trust,Bath, UK
Prof. Juliet Compston (OBE)
Emeritus Professor of Bone Medicine
University of Cambridge, School of Clinical Medicine
Dr. John Edwards
General Practitioner and Senior Lecturer in General Practice
Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, and Wolstanton Medical Centre, Newcastle under Lyme
Dr. Rebecca Low
General Practitioner
Marcham Road Health Centre, Abingdon and Specialty Doctor in Metabolic Bone Disease, Nuffield Orthopaedic Centre, Oxford
Dr. Zoe Paskins
Reader and Honorary Consultant in Rheumatology
School of Medicine, Keele University, Keele. Haywood Academic Rheumatology Centre, Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stoke-on-Trent
Prof. John Kanis
Emeritus Professor in Human Metabolism
Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia and Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield
Mr. Nic Vine
Public and patient representative
Ms. Jean Bowden
Public and patient representative
Ms. Jane Parker
Public and patient representative
Expert Advisory Group
Prof. David M Reid
Emeritus Professor of Rheumatology
University of Aberdeen
Prof. David J Armstrong
Consultant Rheumatologist
Western Health and Social Care Trust (NI), and Visiting Professor, Nutrition Innovation Centre for Food and Health, Ulster University
Prof. Cyrus Cooper (OBE)
Director & Professor of Rheumatology at the MRC Lifecourse Epidemiology Centre (Southampton) Professor of Musculoskeletal Science (Oxford)
MRC Lifecourse Epidemiology Centre, University of Southampton, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, UK; NIHR Oxford Biomedical Research Centre, University of Oxford, UK
Prof. Neil JL Gittoes
Consultant & Honorary Professor of Endocrinology
Queen Elizabeth Hospital, University Hospitals Birmingham & University of Birmingham, Centre for Endocrinology, Diabetes and Metabolism, Birmingham
Prof. Nicholas Harvey
Professor of Rheumatology and Clinical Epidemiology, Honorary Consultant Rheumatologist
MRC Lifecourse Epidemiology Centre, University of Southampton, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, UK
Prof. Eugene McCloskey
Professor in Adult Bone Disease and Honorary Consultant
MRC Versus Arthritis Centre for Integrated research in Musculoskeletal Ageing (CIMA), Mellanby Centre for Musculoskeletal Research, Department of Oncology & Metabolism, University of Sheffield.
Dr. Katie Moss
Consultant Rheumatologist and Honorary Senior Lecturer
St George’s University Hospital, London
Prof. Kenneth Poole
University Professor of Metabolic Bone Disease
University of Cambridge Department of Medicine & Cambridge NIHR Biomedical Research Centre
Dr. Mike Stone
Consultant Physician and Visiting Professor
University Hospital Llandough, Cardiff and Vale University Health Board
Conflicts of interest
Conflict of interests of the members of the two Committees above can be accessed by clicking here
The 2021 NOGG Guideline is supported by
- Association for Clinical Biochemistry and Laboratory Medicine
- Bone Research Society
- British Geriatrics Society
- British Orthopaedic Association
- British Orthopaedic Research Society
- British Menopause Society
- British Society for Rheumatology
- European Calcified Tissue Society
- European Society for Clinical and Economic Aspects of Osteoporosis,Osteoarthritis and Musculoskeletal Diseases
Contact us
Get in touch with the National Osteoporosis Guideline Group
info@nogg.org.uk
Get in touch with our webmaster
info@humacom.com